Mills & Reeve advised the Wellcome Sanger Institute. Mosaic Therapeutics is an oncology therapeutics company dedicated to resolving cancer’s complexity and power new treatments for patients....
Mosaic Therapeutics’ $28 Million Series A Funding Round
NRG Therapeutics’ £16 Million Series A Fundraising
Mills & Reeve advised NRG Therapeutics on the deal. The Stevenage-based life sciences company, founded in 2018, focuses on therapeutic approaches that will restore mitochondrial function...
F-star Therapeutics’ Licence and Collaboration Agreement with Janssen Biotech, Inc.
Mills & Reeve has acted for F-star Therapeutics on the deal. F-star Therapeutics, on its licence and collaboration agreement with Janssen Biotech, Inc. Under the licence...